Algorithmically identifying the meaningful similarities between an assortment of molecules is a critical chemical problem, and one which is only gaining in relevance as data-driven chemistry continues to progress. Effectively addressing this challenge can be achieved through a reformulation of the problem into information theory, cluster-based supervised classification, and the implementation of key concepts, particularly information entropy and mutual information. These concepts are combined with unsupervised learning atop learned chemical spaces to generate meaningful labels for arbitrary collections of molecules. An open-source and highly extensible codebase is provided to undertake these experiments, demonstrate the viability of the approach on known clusters, and glean insights into the learned representations of chemical space within message-passing neural networks, an architecture not readily permitting interpretability. This approach facilitates the interoperability between human chemical knowledge and the algorithmically derived insights, which will continue to become more prevalent in the coming years.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.jcim.1c00519 | DOI Listing |
Lancet Neurol
February 2025
Janssen Research & Development, a Johnson & Johnson Company, Titusville, NJ, USA.
Background: Given burdensome side-effects and long latency for efficacy with conventional agents, there is a continued need for generalised myasthenia gravis treatments that are safe and provide consistently sustained, long-term disease control. Nipocalimab, a neonatal Fc receptor blocker, was associated with dose-dependent reductions in total IgG and anti-acetylcholine receptor (AChR) antibodies and clinically meaningful improvements in the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale in patients with generalised myasthenia gravis in a phase 2 study. We aimed to assess the safety and efficacy of nipocalimab in a phase 3 study.
View Article and Find Full Text PDFPharmaceutics
December 2024
Pharmathen SA, 31 Spartis Str., 14452 Metamorfosi Attica, Greece.
Regulatory authorities typically require bioequivalence to be demonstrated by comparing pharmacokinetic parameters like area under the plasma concentration-time curve (AUC) and maximum plasma concentration (C). Because in certain cases, AUC and C alone may not be adequate to identify formulation differences in early and/or late segments of the dosing interval, partial AUCs (pAUCs) have been proposed as additional metrics to evaluate bioequivalence. Even though cut-off points for pAUCs are usually decided based on clinical relevance, the identification of the correct cut-off range remains elusive in many other cases and tends to contribute to increased pAUC estimate variabilities.
View Article and Find Full Text PDFSensors (Basel)
January 2025
Department of Electrical Engineering, American University of Sharjah, Sharjah 26666, United Arab Emirates.
Accurately identifying and discriminating between different brain states is a major emphasis of functional brain imaging research. Various machine learning techniques play an important role in this regard. However, when working with a small number of study participants, the lack of sufficient data and achieving meaningful classification results remain a challenge.
View Article and Find Full Text PDFMedicina (Kaunas)
January 2025
Department of Neonatology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mures, Romania.
This study investigated and compared with European literature data the incidence, severity, and perinatal risk factors of retinopathy of prematurity (ROP) in preterm infants admitted to the Premature Department of Mureş County Clinical Hospital over a two-year period (January 2022-December 2023). : ROP screening was performed in 96 infants (76.8%) according to professional guidelines.
View Article and Find Full Text PDFBiomolecules
January 2025
Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Acute kidney injury (AKI) and chronic kidney disease (CKD) represent two frequently observed clinical conditions. AKI is characterized by an abrupt decrease in glomerular filtration rate (GFR), generally associated with elevated serum creatinine (sCr), blood urea nitrogen (BUN), and electrolyte imbalances. This condition usually persists for approximately a week, causing a transient reduction in kidney function.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!